Taxhal 30mg Injection

About

Taxhal 30mg Injection is a cytotoxic agent belonging to the taxane class, commonly used in chemotherapy. It exerts its antineoplastic effects by promoting the assembly of microtubules from tubulin dimers and stabilizing them, preventing their depolymerization. This action disrupts the dynamic reorganization of the microtubule network, which is crucial for vital cellular functions like mitosis and interphase processes. Consequently, cancer cells are arrested in the G2/M phase of the cell cycle, leading to inhibition of cell proliferation and induction of apoptosis. This formulation is typically administered intravenously for various cancer indications.

Uses

• Treatment of ovarian cancer
• Management of breast cancer
• Therapy for non-small cell lung cancer
• Used in Kaposi's sarcoma

Directions For Use

Administered intravenously by a healthcare professional. Dosage and schedule are individualized based on the patient's condition and cancer type.

Benefits

• Effective against a range of solid tumors
• Inhibits cancer cell division and growth
• Can induce tumor regression
• Improves survival rates in specific cancers
• Suitable for monotherapy or combination regimens
• Well-tolerated in certain treatment protocols

Side Effects

• Bone marrow suppression (neutropenia)
• Peripheral neuropathy (nerve damage)
• Alopecia (hair loss)
• Nausea and vomiting
• Fatigue and weakness
• Myalgia (muscle pain) and arthralgia (joint pain)
• Diarrhea
• Mucositis (mouth sores)
• Hypersensitivity reactions (allergic reactions)
• Nail changes
• Fluid retention
• Skin rash

Safety Measures

• Alcohol - Avoid or minimize alcohol intake due to potential for increased gastrointestinal upset and liver strain.
• Pregnancy - Contraindicated. Known to cause severe birth defects. Use effective contraception during treatment.
• Breastfeeding - Not recommended. The drug may pass into breast milk and harm the infant.
• Liver - Caution advised. Dose adjustments may be necessary in patients with hepatic impairment to prevent increased systemic exposure and toxicity.
• Kidney - Generally safe, but caution in severe renal impairment. Monitor renal function as appropriate.
• Lung - Monitor for signs of pulmonary toxicity, such as dyspnea or cough, particularly in patients with pre-existing respiratory issues.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.